Anavex Life Sciences Corp (AVXL)

[Hosai]

He says ADL was "trending in the right direction but not totally significant by itself". Obv have to take CEOs words with grain of salt but when you consider this and the other co primary being under p = 0.025 plus the secondary under p = 0.025 plus the brain loss reduction p - 0.0005 (5 in 10,000 chance the improvement was due to chance) plus the new FDA guidance almost like it's written for anavex with them saying ADL can take longer to show in early AD etc so end point not required, the mild side effects, the ease of taking a pill and the low amount of patients screened compared to other AD trials then it it all seems quite bullish in terms of the science. Just have to keep being patient.